• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mfn2 过表达减轻体内 MPTP 神经毒性。

Mfn2 Overexpression Attenuates MPTP Neurotoxicity In Vivo.

机构信息

Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.

出版信息

Int J Mol Sci. 2021 Jan 9;22(2):601. doi: 10.3390/ijms22020601.

DOI:10.3390/ijms22020601
PMID:33435331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7827738/
Abstract

Mitochondrial dysfunction represents a critical event in the pathogenesis of Parkinson's disease (PD). Increasing evidence demonstrates that disturbed mitochondrial dynamics and quality control play an important role in mitochondrial dysfunction in PD. Our previous study demonstrated that MPP induces mitochondrial fragmentation in vitro. In this study, we aimed to assess whether blocking MPTP-induced mitochondrial fragmentation by overexpressing Mfn2 affords neuroprotection in vivo. We found that the significant loss of dopaminergic neurons in the substantia nigra (SN) induced by MPTP treatment, as seen in wild-type littermate control mice, was almost completely blocked in mice overexpressing Mfn2 (hMfn2 mice). The dramatic reduction in dopamine neuronal fibers and dopamine levels in the striatum caused by MPTP administration was also partially inhibited in hMfn2 mice. MPTP-induced oxidative stress and inflammatory response in the SN and striatum were significantly alleviated in hMfn2 mice. The impairment of motor function caused by MPTP was also blocked in hMfn2 mice. Overall, our work demonstrates that restoration of mitochondrial dynamics by Mfn2 overexpression protects against neuronal toxicity in an MPTP-based PD mouse model, which supports the modulation of mitochondrial dynamics as a potential therapeutic target for PD treatment.

摘要

线粒体功能障碍是帕金森病 (PD) 发病机制中的一个关键事件。越来越多的证据表明,线粒体动力学和质量控制的紊乱在 PD 中线粒体功能障碍中发挥重要作用。我们之前的研究表明,MPP 在体外诱导线粒体碎片化。在这项研究中,我们旨在评估通过过表达 Mfn2 来阻止 MPTP 诱导的线粒体碎片化是否能在体内提供神经保护作用。我们发现,MPTP 处理后,野生型同窝对照小鼠的黑质 (SN) 中多巴胺能神经元的显著丢失几乎完全被过表达 Mfn2 (hMfn2 小鼠) 所阻断。MPTP 给药引起的纹状体多巴胺神经元纤维和多巴胺水平的急剧减少在 hMfn2 小鼠中也部分受到抑制。MPTP 诱导的 SN 和纹状体中的氧化应激和炎症反应在 hMfn2 小鼠中显著减轻。hMfn2 小鼠也阻断了由 MPTP 引起的运动功能障碍。总的来说,我们的工作表明,通过过表达 Mfn2 恢复线粒体动力学可以防止基于 MPTP 的 PD 小鼠模型中的神经元毒性,这支持了作为 PD 治疗的潜在治疗靶点的线粒体动力学的调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/73fce32b105c/ijms-22-00601-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/55e2e5fad0a9/ijms-22-00601-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/563e6782a9dd/ijms-22-00601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/a98837133b55/ijms-22-00601-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/e880609d851c/ijms-22-00601-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/20bc6ce18f40/ijms-22-00601-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/df388fa13ce4/ijms-22-00601-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/73fce32b105c/ijms-22-00601-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/55e2e5fad0a9/ijms-22-00601-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/563e6782a9dd/ijms-22-00601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/a98837133b55/ijms-22-00601-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/e880609d851c/ijms-22-00601-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/20bc6ce18f40/ijms-22-00601-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/df388fa13ce4/ijms-22-00601-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22e0/7827738/73fce32b105c/ijms-22-00601-g007.jpg

相似文献

1
Mfn2 Overexpression Attenuates MPTP Neurotoxicity In Vivo.Mfn2 过表达减轻体内 MPTP 神经毒性。
Int J Mol Sci. 2021 Jan 9;22(2):601. doi: 10.3390/ijms22020601.
2
Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.Mfn2 在体外和体内均可保护暴露于百草枯的多巴胺能神经元:对特发性帕金森病的影响。
Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1359-1370. doi: 10.1016/j.bbadis.2017.02.016. Epub 2017 Feb 16.
3
CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.CX3CR1基因敲除对帕金森病小鼠多巴胺能神经元变性的影响因神经毒素和给药途径而异。
Neurotox Res. 2016 Apr;29(3):364-80. doi: 10.1007/s12640-015-9557-5. Epub 2015 Sep 24.
4
Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.胆固醇在帕金森病的MPTP小鼠模型中导致多巴胺能神经元丢失:线粒体功能障碍和氧化应激的参与。
PLoS One. 2017 Feb 7;12(2):e0171285. doi: 10.1371/journal.pone.0171285. eCollection 2017.
5
14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.在帕金森病的MPTP小鼠模型中,14-3-3抑制促进多巴胺能神经元丢失,而14-3-3θ过表达促进恢复。
Neuroscience. 2015 Oct 29;307:73-82. doi: 10.1016/j.neuroscience.2015.08.042. Epub 2015 Aug 24.
6
PHB blocks endoplasmic reticulum stress and apoptosis induced by MPTP/MPP in PD models.PHB 阻断 MPTP/MPP 诱导的 PD 模型中的内质网应激和细胞凋亡。
J Chem Neuroanat. 2021 Apr;113:101922. doi: 10.1016/j.jchemneu.2021.101922. Epub 2021 Feb 11.
7
MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α.MitoQ 通过激活 PGC-1α 增强 Mfn2 依赖性线粒体融合,从而保护 6-OHDA 诱导的 PD 模型中的多巴胺能神经元。
Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2859-2870. doi: 10.1016/j.bbadis.2018.05.018. Epub 2018 May 26.
8
Validity of the MPTP-Treated Mouse as a Model for Parkinson's Disease.经1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)处理的小鼠作为帕金森病模型的有效性。
Mol Neurobiol. 2016 Apr;53(3):1625-1636. doi: 10.1007/s12035-015-9103-8. Epub 2015 Feb 13.
9
Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.小分子TrkB激动剂脱氧格杜宁可保护啮齿动物黑质纹状体多巴胺能神经元免受6-羟基多巴胺和MPTP诱导的神经毒性。
Neuropharmacology. 2015 Dec;99:448-58. doi: 10.1016/j.neuropharm.2015.08.016. Epub 2015 Aug 14.
10
Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.琥珀酸布可洛尔,一种非他汀类降胆固醇药物,可预防帕金森病实验模型中的运动前症状和黑质纹状体神经退行性变。
Mol Neurobiol. 2017 Mar;54(2):1513-1530. doi: 10.1007/s12035-016-9747-z. Epub 2016 Feb 6.

引用本文的文献

1
FL3 mitigates cardiac ischemia-reperfusion injury by promoting mitochondrial fusion to restore calcium homeostasis.FL3通过促进线粒体融合以恢复钙稳态来减轻心脏缺血再灌注损伤。
Cell Death Discov. 2025 Jul 3;11(1):304. doi: 10.1038/s41420-025-02575-w.
2
Effects of latroeggtoxin-VI on dopamine and α-synuclein in PC12 cells and the implications for Parkinson's disease.Latroeggtoxin-VI 对 PC12 细胞中多巴胺和α-突触核蛋白的影响及其对帕金森病的意义。
Biol Res. 2024 Mar 16;57(1):9. doi: 10.1186/s40659-024-00489-y.
3
Apigenin attenuates LPS-induced neurotoxicity and cognitive impairment in mice via promoting mitochondrial fusion/mitophagy: role of SIRT3/PINK1/Parkin pathway.

本文引用的文献

1
The assessment of possible gender-related effect of endogenous striatal alpha-tocopherol level on MPTP neurotoxicity in mice.内源性纹状体α-生育酚水平对小鼠MPTP神经毒性可能存在的性别相关影响的评估。
Heliyon. 2020 Jul 11;6(7):e04425. doi: 10.1016/j.heliyon.2020.e04425. eCollection 2020 Jul.
2
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.线粒体功能障碍在阿尔茨海默病发病机制中的作用:最新进展
Mol Neurodegener. 2020 May 29;15(1):30. doi: 10.1186/s13024-020-00376-6.
3
Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour.
芹菜素通过促进线粒体融合/自噬减轻 LPS 诱导的小鼠神经毒性和认知障碍:SIRT3/PINK1/Parkin 通路的作用。
Psychopharmacology (Berl). 2022 Dec;239(12):3903-3917. doi: 10.1007/s00213-022-06262-x. Epub 2022 Oct 26.
4
Sinapic Acid Ameliorates REV-ERB α Modulated Mitochondrial Fission against MPTP-Induced Parkinson's Disease Model.芥子酸改善REV-ERBα调节的线粒体分裂以对抗MPTP诱导的帕金森病模型。
Biomol Ther (Seoul). 2022 Sep 1;30(5):409-417. doi: 10.4062/biomolther.2022.020. Epub 2022 May 25.
5
Dexmedetomidine Can Enhance PINK1/Parkin-Mediated Mitophagy in MPTP-Induced PD Mice Model by Activating AMPK.右美托咪定通过激活 AMPK 增强 MPTP 诱导的 PD 小鼠模型中 PINK1/Parkin 介导的线粒体自噬。
Oxid Med Cell Longev. 2022 Apr 12;2022:7511393. doi: 10.1155/2022/7511393. eCollection 2022.
6
Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases.基于纳米技术的药物递送策略修复神经炎症和神经退行性疾病中的线粒体功能
Pharmaceutics. 2021 Dec 1;13(12):2055. doi: 10.3390/pharmaceutics13122055.
强迫症相关行为的 SAPAP3 基因敲除模型中的单胺类神经递质异常。
Philos Trans R Soc Lond B Biol Sci. 2018 Mar 19;373(1742). doi: 10.1098/rstb.2017.0023.
4
Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease.线粒体:帕金森病中基因突变和环境毒物的共同靶点
Front Genet. 2017 Nov 17;8:177. doi: 10.3389/fgene.2017.00177. eCollection 2017.
5
Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?帕金森病中的线粒体动态:α-突触核蛋白的作用?
Dis Model Mech. 2017 Sep 1;10(9):1075-1087. doi: 10.1242/dmm.026294.
6
Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.Mfn2 在体外和体内均可保护暴露于百草枯的多巴胺能神经元:对特发性帕金森病的影响。
Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1359-1370. doi: 10.1016/j.bbadis.2017.02.016. Epub 2017 Feb 16.
7
Genetics of Parkinson's disease.帕金森病的遗传学
Mol Cell Probes. 2016 Dec;30(6):386-396. doi: 10.1016/j.mcp.2016.11.001. Epub 2016 Nov 4.
8
Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP.DRP1 线粒体易位抑制在 MPTP 诱导的帕金森病模型中提供多巴胺能系统的神经保护。
Sci Rep. 2016 Sep 13;6:32656. doi: 10.1038/srep32656.
9
Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes.帕金森病相关突变体VPS35通过回收动力蛋白1复合物导致线粒体功能障碍。
Nat Med. 2016 Jan;22(1):54-63. doi: 10.1038/nm.3983. Epub 2015 Nov 30.
10
Neuroinflammation in Parkinson's disease and its potential as therapeutic target.帕金森病中的神经炎症及其作为治疗靶点的潜力。
Transl Neurodegener. 2015 Oct 12;4:19. doi: 10.1186/s40035-015-0042-0. eCollection 2015.